Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Barnett

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1994
Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenograftsE A Neuwelt, P A Barnett, K E Hellström, et al.
Stroke|May 7, 1999
Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque areaJ D Spence, M R Malinow, P A Barnett, et al.
Neurosurgery|September 1, 1993
Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenograftsE A Neuwelt, P A Barnett, F L Ramsey, et al.
Experimental Eye Research|February 1, 1985
Sorbitol/fructose metabolism in the lensH M Cheng, R G González, P A Barnett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agentsE A Neuwelt, P A Barnett, C I McCormick, et al.
AJNR. American Journal of Neuroradiology|September 1, 1991
Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findingsS M Roman-Goldstein, P A Barnett, C I McCormick, et al.
The Journal of Clinical Investigation|August 1, 1979
Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent deliveryE A Neuwelt, K R Maravilla, E P Frenkel, et al.
The American Journal of Pathology|February 1, 1995
Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude ratP A Barnett, S Roman-Goldstein, F Ramsey, et al.
Cancer Research|September 1, 1988
Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruptionE A Neuwelt, P A Barnett, I Hellström, et al.
Cancer Research|June 1, 1985
Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrierE A Neuwelt, E P Frenkel, A N D'Agostino, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1994
Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenograftsE A Neuwelt, P A Barnett, K E Hellström, et al.
Stroke|May 7, 1999
Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque areaJ D Spence, M R Malinow, P A Barnett, et al.
Neurosurgery|September 1, 1993
Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenograftsE A Neuwelt, P A Barnett, F L Ramsey, et al.
Experimental Eye Research|February 1, 1985
Sorbitol/fructose metabolism in the lensH M Cheng, R G González, P A Barnett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agentsE A Neuwelt, P A Barnett, C I McCormick, et al.
AJNR. American Journal of Neuroradiology|September 1, 1991
Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findingsS M Roman-Goldstein, P A Barnett, C I McCormick, et al.
The Journal of Clinical Investigation|August 1, 1979
Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent deliveryE A Neuwelt, K R Maravilla, E P Frenkel, et al.
The American Journal of Pathology|February 1, 1995
Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude ratP A Barnett, S Roman-Goldstein, F Ramsey, et al.
Cancer Research|September 1, 1988
Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruptionE A Neuwelt, P A Barnett, I Hellström, et al.
Cancer Research|June 1, 1985
Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrierE A Neuwelt, E P Frenkel, A N D'Agostino, et al.
Pageof 3